SREBF1 and metabolic dysfunction-associated steatotic liver disease: The PPAR-α, PPAR-β/γ, FAS (fatty acid synthase), GPAT, SREBP-1c, and AMPK signaling influence the upregulation of lipid, triglyceride, and fatty acid synthesis in the liver and play a significant role in the pathogenesis of NAFLD [152,159].